Metraipolis › archive › dc_c472b520cbc3

Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast… — Europe PMC PMID:42466058

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42466058
DOI: 10.30683/1927-7229.2026.15.06
License (as archived): solo-consultazione
Archived: 2026-10-31T19:40:58.181Z
SHA-256 of the archived text: 80fcba8230cdb8fd35f9676efa480bee0b5863a1d4a5126c4a3b6e330c5da71f
Stable URL of this page: https://metraipolis.com/documento/dc_c472b520cbc3

How to cite

Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast… — Europe PMC PMID:42466058 — Europe PMC (en), https://europepmc.org/article/MED/42466058 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c472b520cbc3 (Metraipolis archive dc_c472b520cbc3, sha256 80fcba8230cdb8fd35f9676efa480bee0b5863a1d4a5126c4a3b6e330c5da71f)

BibTeX

@misc{dcc472b520cbc3,
  title = {Initial Evaluation of Dihydroartemisinin (DHA), Metformin and Taro Extract in Combination with Cisplatin for Enhanced Cytotoxicity in Triple-Negative Breast… — Europe PMC PMID:42466058},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42466058},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c472b520cbc3; sha256 80fcba8230cdb8fd35f9676efa480bee0b5863a1d4a5126c4a3b6e330c5da71f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42466058. Agents can read the archived copy with the MCP tool read_document.